Medclair AB (NGM:MCLR)

Market Cap	218.12M +72.8%
Revenue (ttm)	56.07M +30.5%
Net Income	4.65M
EPS	0.06
Shares Out	91.65M
PE Ratio	39.67
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	72,638
Average Volume	78,880
Open	n/a
Previous Close	2.350
Day's Range	n/a
52-Week Range	1.490 - 3.350
Beta	0.88
RSI	48.73
Earnings Date	May 8, 2026

About Medclair AB

Medclair AB, a research and development company, specializes in the measurement, collection, and destruction of nitrous oxide (N2O). It offers mobile destruction unit, a solution that can be moved anywhere, where N2O is needed for pain relief; central destruction unit, a system designed for larger N2O destruction volumes; Recycling Decomposition Unit a, intelligent solution that effectively collects Nitrous Oxide (N2O) from discarded N2O bottles and decomposes it within a self-supporting system; and Nitrous Oxide Detector, an N2O measuring devi...

• Industry: Crude Petroleum and Natural Gas
• Founded: 2005
• Employees: 14
• Stock Exchange: Nordic Growth Market
• Ticker Symbol: MCLR